Apheresis Market by Product (Devices and Disposables), Technology (Centrifugation and Membrane Separation), Procedure (Therapeutic Apheresis (Therapeutic Apheresis Disposables (Blood Disorders, Autoimmune Disorders, Metabolic Disorders, and Neurological Disorders), Therapeutic Apheresis Devices, and Automated Blood Collection)), Application (Photopheresis, Leukapheresis, Plasmapheresis, and Plateletpheresis) and End User (Hospitals and Blood Centers) - Global Analysis & Forecast 2020-2030

Report ID : 332  |  Published Date : Jul 2020  |  Pages : 180  |  Region : Global  |  Report Code : MD-103





Apheresis Market Introduction & Overview

Apheresis is a medical technology that involves removing whole blood from a donor or patient and separating the blood into individual components so that one particular component can be removed, therefore, the remaining blood components then are re-introduced back into the bloodstream of the patient or donor. Apheresis is also called pheresis or hemapheresis. This system collects and separates blood components for donation; they can also remove or exchange substances in therapeutic procedures.

The apheresis market is driven by factors such as wide-scale adoption of such technology, associated benefits, rising patient awareness, and the use of advanced technology in the field of apheresis. Moreover, the increasing prevalence of chronic diseases and the growing number of trauma and injury cases are further adding to the apheresis market growth. However, the high cost of apheresis devices and the high maintenance cost of the apheresis system are factors expected to hamper the industry to a certain extent.

The global apheresis market can be segmented into product, procedure, application, technology, end-user, and region.

Apheresis Market By Product

Based on product type, the market can be segmented into devices and disposables. The devices are further segmented into centrifugal devices and membrane separators. The centrifugal segment is likely to grow at the fastest CAGR during the study period owing to the increasing evidence of the efficacy and safety centrifugal devices and their higher adoption in diagnostic & diagnostic apheresis centres.

Apheresis Market By Procedure

Based on the procedure, the market is categorized into automated blood collection (donor apheresis) and therapeutic apheresis. The therapeutic category is anticipated to grow at the highest rate during the forecast period owing to the rising incidence of various neurological, blood, and renal diseases.

Apheresis Market By Application

Based on the application, the market can be segmented into leukapheresis, plateletpheresis, plasmapheresis, photopheresis, and erythrocytapheresis. The photopheresis segment is anticipated to grow at the highest CAGR during the forecast period. The large highest CAGR of this segment can be attributed to the ongoing technological advancements in the field of apheresis.

Apheresis Market By Technology

Based on the application, the market can be segmented into centrifugation and membrane separation. The centrifugation technology segment is anticipated to grow at the highest CAGR during the study period. The large highest CAGR of this segment can be attributed to its associated benefits over membrane separation technology.

Apheresis Market By End User

Based on the end-user, the market can be segmented into blood collection centres & blood component providers, hospitals and transfusion centres, and other end users. The blood collection centres & blood component providers end-user segment is estimated to account for the largest market share globally. The large share of this segment can be attributed to the availability of the latest technologies in centres and the increasing number of procedures carried out in blood collection centres & blood component providers.

Apheresis Market By Region

Based on the region, the market can be segmented into North America, Europe, Asia-Pacific, and the Rest of the World (ROW). North America dominated the market followed by Europe. The large share of North America can be attributed to the availability of advanced apheresis and rising prevalence of target diseases among the geriatric population in this region.

Apheresis Market Prominent Players

Some of the key players operating in the apheresis market include Terumo Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation, Baxter, B. Braun Melsungen AG, Asahi Kasei Corporation, Cerus Corporation, Kaneka Corporation, Nikkiso Co., Ltd., Sumitomo Bakelite Co., Ltd., among others.